0

IN THIS ISSUE

Archives of General Psychiatry

March 2000, Vol 57, No. 3
Basic View  |  Expanded View
This Month in Archives of General Psychiatry FREE
Topics:
Arch Gen Psychiatry. 2000;57(3):208. doi:10.1001/archpsyc.57.3.208.
A 40-Year Perspective on the Prevalence of Depression:  The Stirling County Study FREE
Jane M. Murphy, PhD; Nan M. Laird, PhD; Richard R. Monson, MD, DSc; Arthur M. Sobol, MA; Alexander H. Leighton, MD
Topics: depressive disorders
Arch Gen Psychiatry. 2000;57(3):209-215. doi:10.1001/archpsyc.57.3.209.
A Comparison of Self-report and Clinical Diagnostic Interviews for Depression:  Diagnostic Interview Schedule and Schedules for Clinical Assessment in Neuropsychiatry in the Baltimore Epidemiologic Catchment Area Follow-up FREE
William W. Eaton, PhD; Karen Neufeld, MD; Li-Shiun Chen, MD; Guojun Cai, MD
Topics: catchment area (health), depressive disorders, psychiatrist
Arch Gen Psychiatry. 2000;57(3):217-222. doi:10.1001/archpsyc.57.3.217.
A Comparison of Diagnostic Interviews for Depression in the Stirling County Study:  Challenges for Psychiatric Epidemiology FREE
Jane M. Murphy, PhD; Richard R. Monson, MD, DSc; Nan M. Laird, PhD; Arthur M. Sobol, MA; Alexander H. Leighton, MD
Topics: depressive disorders, psychiatric epidemiology
Arch Gen Psychiatry. 2000;57(3):230-236. doi:10.1001/archpsyc.57.3.230.
Decreased Glutamic Acid Decarboxylase67 Messenger RNA Expression in a Subset of Prefrontal Cortical γ-Aminobutyric Acid Neurons in Subjects With Schizophrenia FREE
David W. Volk, MS; Mark C. Austin, PhD; Joseph N. Pierri, MS, MD; Allan R. Sampson, PhD; David A. Lewis, MD
Topics: generalized anxiety disorder, glutamic acid, neurons, rna, messenger, schizophrenia
Arch Gen Psychiatry. 2000;57(3):237-245. doi:10.1001/archpsyc.57.3.237.
Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or Haloperidol FREE
Scot E. Purdon, PhD; Barry D. W. Jones, MD; Emanuel Stip, MD; Alan Labelle, MD; Don Addington, MD; Stacy R. David, PhD; Alan Breier, MD; Gary D. Tollefson, MD, PhD; for The Canadian Collaborative Group for Research on Cognition in Schizophrenia
Topics: haloperidol, risperidone, schizophrenia, olanzapine
Arch Gen Psychiatry. 2000;57(3):249-258. doi:10.1001/archpsyc.57.3.249.
Illicit Psychoactive Substance Use, Heavy Use, Abuse, and Dependence in a US Population-Based Sample of Male Twins FREE
Kenneth S. Kendler, MD; Laura M. Karkowski, PhD; Michael C. Neale, PhD; Carol A. Prescott, PhD
Topics: cocaine, central nervous system stimulant, twins, sedative
Arch Gen Psychiatry. 2000;57(3):261-269. doi:10.1001/archpsyc.57.3.261.
Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine:  Support for Hyperglutamatergic Effects of N-methyl-D-aspartate Receptor Antagonists FREE
Amit Anand, MD; Dennis S. Charney, MD; Dan A. Oren, MD; Robert M. Berman, MD; X. Sylvia Hu, PhD; Angela Cappiello, MD, PhD; John H. Krystal, MD
Topics: ketamine, lamotrigine, antagonists, aspartate, attenuation
Arch Gen Psychiatry. 2000;57(3):270-276. doi:10.1001/archpsyc.57.3.270.
A Program for Relapse Prevention in Schizophrenia:  A Controlled Study FREE
Marvin I. Herz, MD; J. Steven Lamberti, MD; Jim Mintz, PhD; Ruth Scott, MS, RN, CS; Susan P. O'Dell, MS, RN, CS; Lisa McCartan, MA; Glen Nix, PhD
Topics: antipsychotic agents, schizophrenia, relapse prevention, positive and negative syndrome scale, mapt gene
Arch Gen Psychiatry. 2000;57(3):277-283. doi:10.1001/archpsyc.57.3.277.
Executive Dysfunction and Long-term Outcomes of Geriatric Depression FREE
George S. Alexopoulos, MD; Barnett S. Meyers, MD; Robert C. Young, MD; Balu Kalayam, MD; Tatsuyuki Kakuma, PhD; Michelle Gabrielle, MSW; Jo Anne Sirey, PhD; James Hull, PhD
Topics: depressive disorders, geriatric depression, executive dysfunction
Arch Gen Psychiatry. 2000;57(3):285-290. doi:10.1001/archpsyc.57.3.285.
Community Diagnosis Counts
Darrel A. Regier, MD, MPH
Topics: validity of results, depressive disorders, epidemiologic studies, mental disorders, memory, disability, psychiatrist, scid interview
Arch Gen Psychiatry. 2000;57(3):223-224. doi:10.1001/archpsyc.57.3.223.
Controversies in Community-Based Psychiatric Epidemiology:  Let the Data Speak for Themselves
Dan G. Blazer, MD, PhD; Berton H. Kaplan, PhD
Topics: psychiatric epidemiology
Arch Gen Psychiatry. 2000;57(3):227-228. doi:10.1001/archpsyc.57.3.227.
Dextromethorphan Challenge in Alcohol-Dependent Patients and Controls
Christian G. Schütz, MD, MPH; Michael Soyka, MD
Topics:
Arch Gen Psychiatry. 2000;57(3):291-292. doi:10.1001/archpsyc.57.3.291.
Dextromethorphan Challenge in Alcohol-Dependent Patients and Controls—Reply
John H. Krystal, MD; Ismene L. Petrakis, MD
Topics:
Arch Gen Psychiatry. 2000;57(3):292. doi:.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems